Literature DB >> 25466975

Arrhythmia burden in elderly patients with severe aortic stenosis as determined by continuous electrocardiographic recording: toward a better understanding of arrhythmic events after transcatheter aortic valve replacement.

Marina Urena1, Salim Hayek1, Asim N Cheema1, Vicenç Serra1, Ignacio J Amat-Santos1, Luis Nombela-Franco1, Henrique B Ribeiro1, Ricardo Allende1, Jean-Michel Paradis1, Eric Dumont1, Vinod H Thourani1, Vasilis Babaliaros1, Jaume Francisco Pascual1, Carlos Cortés1, Bruno García Del Blanco1, François Philippon1, Stamatios Lerakis1, Josep Rodés-Cabau2.   

Abstract

BACKGROUND: This study sought to evaluate the prevalence of previously undiagnosed arrhythmias in candidates for transcatheter aortic valve replacement (TAVR) and to determine the impact on therapy changes and arrhythmic events after the procedure. METHODS AND
RESULTS: A total of 435 candidates for TAVR underwent 24-hour continuous ECG monitoring the day before the procedure. Newly diagnosed arrhythmias were observed in 70 patients (16.1%) before TAVR: paroxysmal atrial fibrillation (AF)/atrial tachycardia (AT) in 28, advanced atrioventricular block or severe bradycardia in 24, nonsustained ventricular tachycardia in 26, and intermittent left bundle-branch block in 3 patients. All arrhythmic events but one were asymptomatic and led to a therapy change in 43% of patients. In patients without known AF/AT, the occurrence of AF/AT during 24-hour ECG recording was associated with a higher rate of 30-day cerebrovascular events (7.1% versus 0.4%; P=0.030). Among the 53 patients with new-onset AF/AT after TAVR, 30.2% had newly diagnosed paroxysmal AF/AT before the procedure. In patients who needed permanent pacemaker implantation after the procedure (n=35), 31.4% had newly diagnosed advanced atrioventricular block or severe bradycardia before TAVR. New-onset persistent left bundle-branch block after TAVR occurred in 37 patients, 8.1% of whom had intermittent left bundle-branch block before the procedure.
CONCLUSIONS: Newly diagnosed arrhythmias were observed in approximately a fifth of TAVR candidates, led to a higher rate of cerebrovascular events, and accounted for a third of arrhythmic events after the procedure. This high arrhythmia burden highlights the importance of an early diagnosis of arrhythmic events in such patients to implement the appropriate therapeutic measures earlier.
© 2014 American Heart Association, Inc.

Entities:  

Keywords:  aortic valve stenosis; arrhythmia; atrial fibrillation; monitoring, ambulatory electrocardiographic; pacemaker, artificial; transcatheter aortic valve implantation

Mesh:

Year:  2014        PMID: 25466975     DOI: 10.1161/CIRCULATIONAHA.114.011929

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  14 in total

Review 1.  Interventional treatment of the aortic valve : Current evidence.

Authors:  F Jansen; N Werner
Journal:  Herz       Date:  2017-09       Impact factor: 1.443

Review 2.  Challenges in Aortic Stenosis: Review of Antiplatelet/Anticoagulant Therapy Management with Transcatheter Aortic Valve Replacement (TAVR): TAVR with Recent PCI, TAVR in the Patient with Atrial Fibrillation, and TAVR Thrombosis Management.

Authors:  Matthew W Sherwood; Amit N Vora
Journal:  Curr Cardiol Rep       Date:  2018-10-11       Impact factor: 2.931

3.  Atrial Fibrillation is Associated with Increased Pacemaker Implantation Rates in the Placement of AoRTic Transcatheter Valve (PARTNER) Trial.

Authors:  Angelo B Biviano; Tamim Nazif; Jose Dizon; Hasan Garan; Mark Abrams; Jessica Fleitman; Dua Hassan; Samir Kapadia; Vasilis Babaliaros; Ke Xu; Josep Rodes-Cabau; Wilson Y Szeto; William F Fearon; Danny Dvir; Todd Dewey; Mathew Williams; Steven Kindsvater; Michael J Mack; John G Webb; D Craig Miller; Craig R Smith; Martin B Leon; Susheel Kodali
Journal:  J Atr Fibrillation       Date:  2017-06-30

Review 4.  Biological functions of the ING family tumor suppressors.

Authors:  E I Campos; M Y Chin; W H Kuo; G Li
Journal:  Cell Mol Life Sci       Date:  2004-10       Impact factor: 9.261

5.  [Prevalence and risk factors of atrial fibrillation in Germany : data from the Gutenberg Health Study].

Authors:  R B Schnabel; S S Johannsen; P S Wild; S Blankenberg
Journal:  Herz       Date:  2015-02       Impact factor: 1.443

6.  Short-term pacemaker dependency after transcatheter aortic valve implantation.

Authors:  Christiana Schernthaner; Johannes Kraus; Franz Danmayr; Matthias Hammerer; Jens Schneider; Uta C Hoppe; Bernhard Strohmer
Journal:  Wien Klin Wochenschr       Date:  2016-01-08       Impact factor: 1.704

Review 7.  Atrioventricular and intraventricular block after transcatheter aortic valve implantation.

Authors:  Jane J Lee; Nora Goldschlager; Vaikom S Mahadevan
Journal:  J Interv Card Electrophysiol       Date:  2018-06-24       Impact factor: 1.900

8.  Mechanisms of Heart Block after Transcatheter Aortic Valve Replacement - Cardiac Anatomy, Clinical Predictors and Mechanical Factors that Contribute to Permanent Pacemaker Implantation.

Authors:  Mark Young Lee; Srinath Chilakamarri Yeshwant; Sreedivya Chava; Daniel Lawrence Lustgarten
Journal:  Arrhythm Electrophysiol Rev       Date:  2015-08

9.  Trends and effect of atrial fibrillation on inpatient outcomes after transcatheter aortic valve replacement.

Authors:  Nikita Patil; Paula D Strassle; Sameer Arora; Chinmay Patel; Kishorbhai Gangani; John P Vavalle
Journal:  Cardiovasc Diagn Ther       Date:  2020-02

10.  Natriuretic peptide receptor B maintains heart rate and sinoatrial node function via cyclic GMP-mediated signalling.

Authors:  Tristan W Dorey; Martin Mackasey; Hailey J Jansen; Megan D McRae; Loryn J Bohne; Yingjie Liu; Darrell D Belke; Logan Atkinson; Robert A Rose
Journal:  Cardiovasc Res       Date:  2022-06-29       Impact factor: 13.081

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.